Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Skip to main content

$15 Million for NF Research is Now Official

By September 28, 2018December 5th, 2023Advocacy

President Signs Bill with $15 Million for NF Research

After receiving approval from both chambers of Congress earlier this month, President Trump signed the FY 2019 Defense and Labor, Health, and Human Services Appropriations conference report into law on Friday, September 28.  The conference report includes $15 million in funding to support neurofibromatosis research and is vital to our fight to end NF.  This funding will support strategic research through the Department of Defense’s Neurofibromatosis Research Program (NFRP), resulting in new discoveries and better outcomes for NF patients and their families.  Today would not be a reality without the tireless work and advocacy done by the Children’s Tumor Foundation, the NF Community, patients, and their families.  We should note that having received questions about some earlier announcements made this month in the NF community about this funding, it is only today – after both houses and the President have approved the funding – that this funding is now a reality. This sustained federal funding will allow us to further develop scientific data, break through barriers, and forge a pathway to end NF.

Close Menu